Clinician Satisfaction With the VERABAND™
ConditionChronic Low-back Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity of Michigan
About this trial
The VERABAND™ is a newly-developed, disposable, wearable activity monitor. The researchers will assess clinician satisfaction with the usability and likelihood of clinical adoption of the newly-developed, disposable, wearable activity monitor, across multiple clinical sites in the chronic low back pain (cLBP) population.
Eligibility criteria
Qualifiers
Ambulatory
Diagnosis of chronic low back pain (cLBP) according to the criteria of National Institute of Health (NIH) Task Force on Research Standards for cLBP
Answering 'Yes' to the question: Does your low back pain interfere with your mobility?
Starting any new non-surgical treatment or combination of treatments for cLBP as part of their normal ongoing care, including medications; physical therapy/exercise; integrated therapies (e.g., massage, acupuncture, yoga); cognitive- behavioral therapy; and/or interventional procedures (e.g., epidural steroid or facet joint injections)
Disqualifiers
Clinical findings suggesting the presence of ongoing systemic disease, including fever, weight loss, initiation of pain following major trauma, immunosuppression, intravenous drug use, recent bacterial infection, severe or persistent sensory or motor involvement of bowel, bladder, or lower extremity; or any condition that would greatly limit physical activity not due to pain.
Inability to speak and write English.
Visual or hearing difficulties that would preclude participation.
Severe psychiatric disorders that in the opinion of the investigative team would interfere with participation in the study. This includes any active suicidal ideations or history of suicide attempts. Exclusions will be based on self-reported medical history or chart review and in accordance with Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria.
Trial design
Treatments tested in this trial
- VERABAND information
Treatment groups
360 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Michigan
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Arbor Medical Innovations, LLC
Collaborator
Source ClinicalTrials.gov